{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:19:21Z","timestamp":1762899561052},"reference-count":19,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"National Institute for Health Development, Estonia","award":["20131102"],"award-info":[{"award-number":["20131102"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aim of the study was to assess indicator condition (IC) guided HIV testing in Estonia from 2012\u20132015.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used Estonian Health Insurance Fund (EHIF) data. EHIF is the core purchaser of health care services in Estonia, covering health care costs for insured people (94% of the total population). After health care services\u2019 provision, the provider sends an invoice to EHIF, which includes patient information (e.g. age, gender, diagnoses based on ICD\u201010) and services provided (e.g. what tests were performed).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the ICs analysed, the highest proportion of patients tested was among those presenting with infectious mononucleosis\u2010like illness (27\u201333% of patients) and viral hepatitis (28\u201332%), the lowest proportion of patients tested was among those presenting with herpes zoster (4\u20135%) and pneumonia (4\u20138%). Women were tested somewhat less than men, especially in cases of sexually transmitted infections (9\u201313% and 18\u201321%, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our data shows that IC\u2010guided HIV testing rates are low in Estonia. Therefore, it is critical to follow Estonian HIV testing guidelines, which recommend IC\u2010guided testing. In general, health insurance data can be used to monitor IC\u2010guided HIV testing.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12586","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T10:45:28Z","timestamp":1519814728000},"page":"47-51","source":"Crossref","is-referenced-by-count":7,"title":["Monitoring HIV\u2010indicator condition guided HIV testing in Estonia"],"prefix":"10.1111","volume":"19","author":[{"given":"K","family":"R\u00fc\u00fctel","sequence":"first","affiliation":[{"name":"National Institute for Health Development Tallinn Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Lemsalu","sequence":"additional","affiliation":[{"name":"National Institute for Health Development Tallinn Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"L\u00e4tt","sequence":"additional","affiliation":[{"name":"Estonian Health Insurance Fund Tallinn Estonia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"OptTEST by HiE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12022"},{"volume-title":"HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings","year":"2012","author":"HiE","key":"e_1_2_7_3_1"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-2-175"},{"key":"e_1_2_7_5_1","unstructured":"ECDC.HIV testing in Europe. Evaluation of the Impact of the ECDC Guidance on HIV Testing: Increasing Uptake and Effectiveness in the European Union.Stockholm:European Centre for Disease Prevention and Control 2016."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051312"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2015-052073"},{"key":"e_1_2_7_8_1","unstructured":"Population statistics.Tallinn: Statistics Estonia 2017. Available from:http:\/\/www.stat.ee\/en(accessed 5 July 2017)."},{"volume-title":"HIV\/AIDS Surveillance in Europe 2015","year":"2016","author":"ECDC","key":"e_1_2_7_9_1"},{"key":"e_1_2_7_10_1","unstructured":"NIHD.HIV in Estonia. Narrative Report for Global AIDS Monitoring 2017.Tallinn:National Institute for Health Development 2017."},{"key":"e_1_2_7_11_1","unstructured":"SoM.HIV\u2010nakkuse testimise ja HIV\u2010positiivsete isikute ravile suunamise tegevusjuhis.Tallinn:Sotsiaalministeerium 2012."},{"key":"e_1_2_7_12_1","unstructured":"ViikleppP.Tuberkuloosihaigestumus Eestis 2012\u20132013.Tallinn:National Institute for Health Development 2014."},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-473"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052845"},{"key":"e_1_2_7_15_1","unstructured":"HIV and AIDS.Tallinn:Health Board 2017. Available athttp:\/\/www.terviseamet.ee\/nakkushaigused\/nakkushaigustesse-haigestumine\/hiv-ja-aids.html(accessed 5 July 2017)"},{"key":"e_1_2_7_16_1","unstructured":"Communicable diseases in Estonia in 2011\u20102016.Tallinn:Health Board 2017. Available athttp:\/\/www.terviseamet.ee\/fileadmin\/dok\/Nakkushaigused\/statistika\/2017\/NH_Eestis_2011-2016.pdf(accessed 5 July 2017)"},{"key":"e_1_2_7_17_1","unstructured":"Communicable diseases immunoprophylaxis and surveillance in Estonia in 2015.Tallinn:Health Board 2016. Available athttp:\/\/www.terviseamet.ee\/fileadmin\/dok\/Nakkushaigused\/statistika\/2015\/Epid_ylevaade_2015.pdf(accessed 5 July 2017)"},{"key":"e_1_2_7_18_1","unstructured":"R\u00fc\u00fctelK LemsaluL.Monitoring HIV testing guidance implementation in Estonia. HepHIV 2017 Conference: HIV and Viral Hepatitis: Challenges of Timely Testing and Care Malta 2017."},{"key":"e_1_2_7_19_1","unstructured":"UNAIDS.The gap report.Geneva:Joint United Nations Programme on HIV\/AIDS 2014. Available athttp:\/\/files.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2014\/UNAIDS_Gap_report_en.pdf(accessed 5 July 2017)"},{"key":"e_1_2_7_20_1","unstructured":"R\u00fc\u00fctelK TrummalA Saleke\u0161inM PervilhacC.HIV epidemic in Estonia: Analysis of strategic information. Case\u00a0study.Geneva World Health Organization 2011."}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12586","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:25:50Z","timestamp":1694445950000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":19,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/hiv.12586"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12586","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}